State Street Corp Xenon Pharmaceuticals Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

A detailed history of State Street Corp transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 246,812 shares of XENE stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246,812
Previous 242,640 1.72%
Holding current value
$10.1 Million
Previous $10.4 Million 7.87%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$36.25 - $43.75 $151,235 - $182,525
4,172 Added 1.72%
246,812 $9.62 Million
Q1 2024

May 15, 2024
BUY
$42.66 - $50.04 $665,496 - $780,624
15,600 Added 6.87%
242,640 $10.4 Million
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $421,029 - $681,568
14,670 Added 6.91%
227,040 $10.5 Million
Q3 2023

Nov 14, 2023
SELL
$34.16 - $39.73 $6,148 - $7,151
-180 Reduced 0.08%
212,370 $7.25 Million
Q2 2023

Aug 14, 2023
BUY
$34.84 - $43.54 $177,474 - $221,792
5,094 Added 2.46%
212,550 $8.18 Million
Q1 2023

May 15, 2023
BUY
$33.46 - $40.35 $335,269 - $404,307
10,020 Added 5.08%
207,456 $7.42 Million
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $894,768 - $1.07 Million
27,065 Added 15.89%
197,436 $7.78 Million
Q3 2022

Nov 15, 2022
SELL
$30.79 - $39.82 $826,711 - $1.07 Million
-26,850 Reduced 13.61%
170,371 $6.15 Million
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $641,952 - $887,227
25,234 Added 14.67%
197,221 $6 Million
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $269,416 - $355,749
10,738 Added 6.66%
171,987 $5.26 Million
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $215,311 - $488,590
13,802 Added 9.36%
161,249 $5.04 Million
Q3 2021

Nov 15, 2021
BUY
$14.86 - $19.45 $250,420 - $327,771
16,852 Added 12.9%
147,447 $2.25 Million
Q2 2021

Aug 16, 2021
BUY
$16.81 - $20.0 $546,442 - $650,140
32,507 Added 33.14%
130,595 $2.43 Million
Q1 2021

May 17, 2021
BUY
$13.65 - $21.31 $64,182 - $100,199
4,702 Added 5.04%
98,088 $1.76 Million
Q4 2020

Feb 16, 2021
BUY
$9.49 - $16.04 $36,432 - $61,577
3,839 Added 4.29%
93,386 $1.44 Million
Q3 2020

Nov 10, 2020
BUY
$10.82 - $13.35 $31,194 - $38,488
2,883 Added 3.33%
89,547 $991,000
Q2 2020

Aug 14, 2020
BUY
$10.21 - $14.9 $691,074 - $1.01 Million
67,686 Added 356.66%
86,664 $1.09 Million
Q1 2020

May 11, 2020
BUY
$8.08 - $17.57 $153,342 - $333,443
18,978 New
18,978 $215,000

Others Institutions Holding XENE

# of Institutions
221
Shares Held
69.6M
Call Options Held
59.7K
Put Options Held
60.7K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.54B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email